What is Restor3d?
Restor3d is a pioneering medical device firm based in Durham, North Carolina, dedicated to enhancing surgical outcomes in human body reconstruction and repair. The company leverages cutting-edge 3D printing technology to create implants with superior anatomical fit and integration properties. By combining expertise in advanced biomedical materials, sophisticated anatomic and kinematic modeling, and AI-driven planning tools, Restor3d aims to revolutionize the medical device landscape, offering surgeons advanced solutions for complex procedures.
How much funding has Restor3d raised?
Restor3d has raised a total of $324.1M across 7 funding rounds:
Unspecified
$4.3M
Other Financing Round
$23M
Series A
$55M
Private Equity
$15M
Multiple Rounds
$226.8M
Unspecified (2020): $4.3M, investors not publicly disclosed
Other Financing Round (2022): $23M, investors not publicly disclosed
Series A (2024): $55M supported by Summers Value Partners
Private Equity (2024): $15M featuring Trinity Capital
Other Financing Round (2025): $38M backed by Summers Value Partners and Trinity Capital
Private Equity (2025): $84.8M, investors not publicly disclosed
Private Equity (2025): $104M led by Partners Group
Key Investors in Restor3d
Partners Group
Partners Group is a global private market investment manager with a broad institutional investor base, suggesting a focus on significant growth-stage companies with strong market potential.
Summers Value Partners
Summers Value Partners is a boutique investment manager specializing in concentrated value investing within the healthcare sector, indicating a strategic interest in Restor3d's innovative medical device solutions.
Trinity Capital
Trinity Capital provides debt financing to growth-stage companies backed by venture capital, signaling their confidence in Restor3d's business model and future revenue generation capabilities.
What's next for Restor3d?
The substantial enterprise-level backing Restor3d has garnered, including its recent major strategic investment, positions the company for significant scaling and market penetration. This infusion of capital is likely to accelerate product development, expand manufacturing capabilities, and bolster commercialization efforts. With a focus on innovation in 3D printed orthopedic implants, Restor3d is poised to capture a larger share of the reconstructive surgery market, potentially leading to further strategic partnerships or future funding rounds as it continues to advance its technology and clinical applications.
See full Restor3d company page
